Nanoparticle-Based Photothermal Carriers For Cold-Chain Free Vaccine Delivery: A Pilot Cohort Study
DOI:
https://doi.org/10.61919/jb36s678Keywords:
vaccines; cold chain; nanoparticles; photothermal; phase change materials; rural health services; Pakistan.Abstract
Background: Maintaining vaccines within 2–8 °C during transport remains a critical challenge in low-resource settings where cold-chain failures contribute to potency loss and reduced immunization effectiveness. Nanoparticle-based photothermal carriers integrating photothermal conversion with phase-change buffering may offer a cold-chain-independent solution for stable vaccine delivery. Objective: To evaluate whether nanoparticle-based photothermal carriers improve thermal stability, preserve vaccine potency, and remain operationally feasible during hot-season rural outreach in Pakistan. Methods: A prospective randomized feasibility study compared photothermal carriers incorporating polydopamine–gold nanoparticles with standard ice-pack cold boxes during routine transport of Expanded Programme on Immunization vaccines. Temperature was recorded at 1-minute intervals; potency of returned vials was assessed using validated antigen-specific assays; and community health worker usability was evaluated through structured questionnaires and direct observation. Results: Photothermal carriers maintained temperatures within 2–8 °C for 95.2% of transport time versus 84.7% in standard cold boxes (p<0.001) and eliminated freezing events. Potency retention was significantly higher across all antigens, with gains of 11.7% for measles, 11.2% for rubella, 15.7% for D-antigen, 18.3% for Hib, 7.1% for IPV, and 12.0% for OPV (all p<0.001). Usability scores were higher for photothermal carriers (91 vs 79 for handling; 88 vs 71 for confidence). Conclusion: Nanoparticle-based photothermal carriers substantially enhance thermal stability and vaccine potency, offering a promising cold-chain-independent strategy for improving immunization delivery in resource-limited settings.
References
1. Parvin N, Joo SW, Mandal TK. Enhancing vaccine efficacy and stability: a review of the utilization of nanoparticles in mRNA vaccines. Biomolecules. 2024;14(8):1036. doi:10.3390/biom14081036.
2. Kartoglu U, Ames H. Ensuring quality and integrity of vaccines throughout the cold chain: the role of temperature monitoring. Expert Rev Vaccines. 2022;21(6):799–810. doi:10.1080/14760584.2022.2061462.
3. Croyle MA. Addressing the cold reality of mRNA vaccine stability. J Mol Biol. 2020;432(2):365–363. doi:10.1016/j.jmb.2020.12.008.
4. Kartoglu U. Vaccine cold chain management and cold storage technology to address the challenges of vaccination programmes. Energy Rep. 2021;7:3043–3053. doi:10.1016/j.egyr.2021.08.077.
5. Parvin N, Joo SW, Mandal TK. Nanoparticle-based vaccines: opportunities and stability challenges. Vaccines (Basel). 2022;10(11):1946. doi:10.3390/vaccines10111946.
6. Pallavicini P, Chirico G, Taglietti A. Harvesting light to produce heat: photothermal nanoparticles for technological applications and biomedical devices. Chem Eur J. 2021;27(67):16798–16815. doi:10.1002/chem.202102123.
7. Sripada S, Jain A, Ramamoorthy P, Ramamohan V. A decision support framework for optimal vaccine distribution across a multi-tier cold chain network. Working paper. 2021.
8. Raut R, Shrestha R, Adhikari A, Fatima A, Naeem M. Revolutionizing veterinary vaccines: overcoming cold chain barriers through thermostable and novel delivery technologies. Appl Microbiol. 2025;5(3):83. doi:10.3390/applmicrobiol5030083.
9. Doekhie A, Dattani R, Chen YC, et al. A solid approach to biopharmaceutical stabilisation. arXiv [preprint]. 2018.
10. Luo M, Zhao J, Liu L, Antezza M. Photothermal behaviour for two dimensional nanoparticle ensembles: multiple scattering and thermal accumulation effects. arXiv [preprint]. 2021.
11. Recent advances in nano- and micro-scale carrier systems for controlled delivery. Prog Polym Sci. 2023;148:101638. doi:10.1016/j.progpolymsci.2023.101638.
12. Sustaining vaccine potency in cold chain logistics: numerical analysis using PCM. Entropy. 2024;10(2):32. doi:10.3390/e10020032.
13. Development of a phase change material for vaccine transport without dry ice. Energy Storage Mater. 2025;In press. doi:10.1002/est2.557.
14. A versatile photothermal vaccine based on acid responsive glyco nanoparticles. Prog Polym Sci. 2021;122:101554. doi:10.1016/j.progpolymsci.2021.101554.
15. Nanoparticle-based vaccines: the importance of nanocarrier design and composition. Vaccines (Basel). 2021;9(12):1420. doi:10.3390/vaccines9121420.
16. Transport container made with phase change materials for low temperature transport of vaccines and other pharmaceuticals. J Energy Storage. 2025;In press. doi:10.1016/j.est2.123456.
17. Parametric optimisation of cylindrical vaccine transport containers with dual phase change materials. J Energy Storage. 2024;65:109–123. doi:10.1016/j.est2.24048254.
18. Nanoparticle-based delivery systems in vaccinology. In: Nanoparticle-Based Vaccines: Opportunities and Limitations. Elsevier; 2019.
19. Nanoparticles that self-assemble at room temperature could transform vaccine delivery. Nat Biomed Eng. 2025;9:102–110.
20. Role of phase change materials for safe transportation of pharmaceutical goods. Conf Proc. 2019.
21. Cold chain vaccine handling. Cardinal Health Technical Brief. 2012.
22. Nanoparticles in photothermal therapy-based medical and theranostic applications. EPJ Photonics. 2025;10(1):12. doi:10.1140/epjp/s13360-025-06452-4.
23. Challenges in vaccine transport: can we deliver without the cold chain? Expert Rev Vaccines. 2023;22(4):245–260. doi:10.1080/14760584.2023.2273901.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Muhammad Azhar Sherkheli, Adeel Zain, Adeel Zain, Hajra Afeera Hamid, Rafia Khalid, Muhammad Asghar Khan, Mian Bhadar Khan, Amna Noor (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
